IL-23 is highly expressed in a broad spectrum of cancers, including colon cancer [13], and has emerged as a new player in the promotion of tumor growth and development through suppression of tumor infiltration of CD8+ T cells and the advancement of tumor angiogenesis and metastases [8,14]. This evidence concerns the gene CD8A and neoplasm.